CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,328,475 | -1.7% | 29,268 | +21.5% | 0.07% | 0.0% |
| Q2 2023 | $1,352,076 | +4.5% | 24,084 | -15.8% | 0.07% | -8.8% |
| Q1 2023 | $1,293,985 | +264.5% | 28,609 | +227.6% | 0.08% | +247.8% |
| Q4 2022 | $354,996 | -36.2% | 8,733 | +2.7% | 0.02% | -42.5% |
| Q3 2022 | $556,000 | +12.3% | 8,506 | +4.5% | 0.04% | +29.0% |
| Q2 2022 | $495,000 | -10.2% | 8,142 | -7.2% | 0.03% | +34.8% |
| Q1 2022 | $551,000 | – | 8,771 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |